← Back to Search

Intraocular Lens

Intraocular Lens Implants for Cataracts

N/A
Recruiting
Led By George O Waring IV, MD FACS
Research Sponsored by George O. Waring IV
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up postoperative 6 months
Awards & highlights

Study Summary

This trial is testing two different intraocular lenses (IOLs) to see which one provides better vision for cataract patients. The study will compare the clinical outcomes and patient satisfaction of the two IOLs.

Who is the study for?
This trial is for individuals aged 40 or older who need cataract surgery in both eyes and want to be free from glasses. They should have less than 0.75 D of astigmatism after the operation, be able to give consent, and follow study rules. People with previous eye surgeries, trauma, certain eye conditions like glaucoma or macular degeneration that affect vision clarity are excluded.Check my eligibility
What is being tested?
The study tests two types of intraocular lenses (IOLs) - Tecnis Synergy and Symfony Optiblue - by implanting one type in each eye of a patient after cataract removal. The goal is to see if patients can see well at all distances without glasses and help surgeons choose the best IOL for future patients.See study design
What are the potential side effects?
While specific side effects aren't listed here, generally speaking, risks associated with intraocular lens implants include inflammation, infection risk increase post-surgery, visual disturbances such as glare or halos around lights, and potential lens dislocation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~postoperative 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and postoperative 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Binocular distance-corrected intermediate visual acuity under photopic conditions.
Binocular distance-corrected near visual acuity under photopic conditions.
Binocular distance-corrected very near visual acuity under photopic conditions.
Secondary outcome measures
Binocular uncorrected distance visual acuity under photopic conditions
Binocular uncorrected intermediate visual acuity under photopic conditions
Binocular uncorrected near visual acuity under photopic conditions
+3 more
Other outcome measures
Binocular distance-corrected intermediate visual acuity under mesopic conditions
Binocular distance-corrected near visual acuity under mesopic conditions
Binocular distance-corrected very near visual acuity under mesopic conditions
+4 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Contralateral implantation of Tecnis Synergy and Tecnis Symfony IOLsExperimental Treatment1 Intervention
Non-comparative study involving contralateral implantation of Tecnis Synergy and Tecnis Symfony IOLs.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intraocular lens
2022
Completed Phase 4
~470

Find a Location

Who is running the clinical trial?

George O. Waring IVLead Sponsor
Johnson & Johnson Surgical Vision, Inc.Industry Sponsor
34 Previous Clinical Trials
8,028 Total Patients Enrolled
29 Trials studying Cataract
6,799 Patients Enrolled for Cataract
George O Waring IV, MD FACSPrincipal InvestigatorWaring Vision Institute

Media Library

Tecnis Synergy and Symfony Intraocular Lens (Intraocular Lens) Clinical Trial Eligibility Overview. Trial Name: NCT05541796 — N/A
Cataract Research Study Groups: Contralateral implantation of Tecnis Synergy and Tecnis Symfony IOLs
Cataract Clinical Trial 2023: Tecnis Synergy and Symfony Intraocular Lens Highlights & Side Effects. Trial Name: NCT05541796 — N/A
Tecnis Synergy and Symfony Intraocular Lens (Intraocular Lens) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05541796 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has recruitment for this research begun?

"According to the info on clinicaltrials.gov, this experiment is not presently looking for individuals. The trial was originally uploaded on September 19th 2022 and recently edited on September 12th 2022. However there are 124 other investigations actively recruiting now if someone desires to participate in a medical study."

Answered by AI

What outcome is this research endeavor attempting to prove?

"This research study has a three month evaluation period, with binocular distance-corrected near visual acuity under photopic conditions as the primary objective. Secondary objectives include subjective patient satisfaction and PRSIQ scores of spectacle independence, mean logMAR uncorrected binocular distance vision at 66 cm, and intermediate visual acuity also measured in logMAR units."

Answered by AI

Who else is applying?

What state do they live in?
Florida
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
Recent research and studies
clinicaltrials.govStudy
Clinical Outcomes Following Implantation of Tecnis Synergy and Symfony Intraocular Lens
George O. Waring IV 2022. "Clinical Outcomes Following Implantation of Tecnis Synergy and Symfony Intraocular Lens". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05541796.
All > Intraocular Lens
~12 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top